Sotac Pharmaceuticals Ltd
SOTACSotac Pharmaceuticals Ltd
SOTACHealth CarePharmaceuticals
SmallcapWith a market cap of ₹139 cr, stock is ranked 2,507
High RiskStock is 6.54x as volatile as Nifty
126.000.00% (+0.00)
126.000.00% (+0.00)
Price Chart
High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
38.78 | 7.07 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
52.80 | 5.98 | 0.57% |
Forecast & Ratings
Detailed Forecast—
Forecast data is currently unavailable for this stockPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
The Company specializes in the manufacturing of a range of pharmaceutical products, such as Non Beta-Lactam (general) tablets, Non Beta-Lactam (general) capsules, Non Beta-Lactam syrup, and external preparations.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
PE Ratio
43.01
1Y Return
56.82%
Buy Reco %
80.65
Cipla Ltd
PE Ratio
40.92
1Y Return
54.75%
Buy Reco %
65.63
Dr Reddy's Laboratories Ltd
PE Ratio
23.23
1Y Return
28.22%
Buy Reco %
35.29
Zydus Lifesciences Ltd
PE Ratio
50.71
1Y Return
83.11%
Buy Reco %
48.15
Mankind Pharma Ltd
PE Ratio
72.93
1Y Return
62.76%
Buy Reco %
58.33
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Revenue Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Earnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some time
Income
Balance Sheet
Cash Flow
Annual Normal View
Income Statement
Annual Normal View
Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | |||||
---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 29.36 | 43.79 | 73.36 | 77.83 | 96.50 | |||||
Raw Materials | 21.16 | 35.55 | 57.58 | 61.68 | 85.95 | |||||
Power & Fuel Cost | 0.52 | 0.72 | 0.86 | 1.37 | ||||||
Employee Cost | 1.60 | 2.14 | 2.13 | 2.58 | ||||||
Selling & Administrative Expenses | 1.35 | 1.32 | 1.57 | 4.22 | ||||||
Operating & Other expenses | 2.07 | 0.84 | 4.82 | -0.26 | ||||||
EBITDA | 2.66 | 3.22 | 6.40 | 8.24 | 10.55 | |||||
Depreciation/Amortization | 1.07 | 1.11 | 1.13 | 2.28 | 2.82 | |||||
PBIT | 1.59 | 2.11 | 5.27 | 5.96 | 7.73 | |||||
Interest & Other Items | 0.36 | 0.61 | 0.59 | 2.04 | 2.76 | |||||
PBT | 1.23 | 1.50 | 4.68 | 3.92 | 4.97 | |||||
Taxes & Other Items | 0.00 | 0.00 | 1.40 | 1.64 | 1.38 | |||||
Net Income | 1.23 | 1.50 | 3.28 | 2.28 | 3.59 | |||||
EPS | 5.35 | 6.52 | 14.26 | 4.41 | 4.46 | |||||
DPS | — | 0.00 | 2.00 | 0.00 | 0.00 | |||||
Payout ratio | 0.00 | 0.00 | 0.14 | 0.00 | 0.00 |
Company Updates
Peers & Comparison
Comparing 3 stocks from
Health CarePharmaceuticalsCompare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Sotac Pharmaceuticals Ltd | 61.07 | 7.07 | — |
Sun Pharmaceutical Industries Ltd | 43.01 | 6.14 | 0.76% |
Cipla Ltd | 40.92 | 4.83 | 0.60% |
Dr Reddy's Laboratories Ltd | 23.23 | 4.50 | 0.64% |
Price Comparison
Compare SOTAC with any stock or ETFCompare SOTAC with any stock or ETF
SOTAC
Shareholdings
Promoter Holdings Trend
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Apr 2023
Sep 2023
Shareholding History
Foreign Institutions
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Dividends
Hmm, looks like data is unavailable here. Please come back after some time
News & Opinions
Articles & Videos
Hmm, looks like data is unavailable here. Please come back after some time.
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant